We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients

News   May 16, 2013

 
Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Muscle Stem Cell Growth Growth Driver May Be Valid Target for Wasting Disorders

News

Lying within our muscles are stem cells, invisible engines that drive the tissue’s growth and repair. Understanding the signal(s) that direct muscle stem cells to spring into action could uncover new ways to promote muscle growth.

READ MORE

“Reverse Engineering” Brain Cancer Stem Cells to Expose Their Vulnerabilities

News

Scientists have "reverse engineered" brain cancer stem cells gene by gene, uncovering multiple potential targets for this hard-to-treat cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE